These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 15998711)

  • 1. Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice.
    Nakanishi M; Saito Y; Kishimoto I; Harada M; Kuwahara K; Takahashi N; Kawakami R; Nakagawa Y; Tanimoto K; Yasuno S; Usami S; Li Y; Adachi Y; Fukamizu A; Garbers DL; Nakao K
    Hypertension; 2005 Aug; 46(2):441-7. PubMed ID: 15998711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
    Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
    Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
    Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
    Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen contributes to gender-related cardiac hypertrophy and fibrosis in mice lacking the gene encoding guanylyl cyclase-A.
    Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Hamanaka I; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
    Endocrinology; 2004 Feb; 145(2):951-8. PubMed ID: 14592959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The specific mineralocorticoid receptor blocker eplerenone attenuates left ventricular remodeling in mice lacking the gene encoding guanylyl cyclase-A.
    Zhang Q; Saito Y; Naya N; Imagawa K; Somekawa S; Kawata H; Takeda Y; Uemura S; Kishimoto I; Nakao K
    Hypertens Res; 2008 Jun; 31(6):1251-6. PubMed ID: 18716375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis.
    Ellmers LJ; Knowles JW; Kim HS; Smithies O; Maeda N; Cameron VA
    Am J Physiol Heart Circ Physiol; 2002 Aug; 283(2):H707-14. PubMed ID: 12124219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene.
    Nishikimi T; Hagaman JR; Takahashi N; Kim HS; Matsuoka H; Smithies O; Maeda N
    Cardiovasc Res; 2005 Apr; 66(1):94-103. PubMed ID: 15769452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
    Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
    Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
    Holtwick R; van Eickels M; Skryabin BV; Baba HA; Bubikat A; Begrow F; Schneider MD; Garbers DL; Kuhn M
    J Clin Invest; 2003 May; 111(9):1399-407. PubMed ID: 12727932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmitral inflow pattern assessed by Doppler echocardiography in angiotensin II type 1A receptor knockout mice with myocardial infarction.
    Nakamura Y; Yoshiyama M; Omura T; Yoshida K; Kim S; Takeuchi K; Iwao H; Yoshikawa J
    Circ J; 2002 Feb; 66(2):192-6. PubMed ID: 11999647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload.
    Patel JB; Valencik ML; Pritchett AM; Burnett JC; McDonald JA; Redfield MM
    Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H777-84. PubMed ID: 15778276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natriuretic peptides buffer renin-dependent hypertension.
    Demerath T; Staffel J; Schreiber A; Valletta D; Schweda F
    Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1489-98. PubMed ID: 24717731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart.
    Ogawa Y; Tamura N; Chusho H; Nakao K
    Can J Physiol Pharmacol; 2001 Aug; 79(8):723-9. PubMed ID: 11558681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggravated renal tubular damage and interstitial fibrosis in mice lacking guanylyl cyclase-A (GC-A), a receptor for atrial and B-type natriuretic peptides.
    Yoshihara F; Tokudome T; Kishimoto I; Otani K; Kuwabara A; Horio T; Kawano Y; Kangawa K
    Clin Exp Nephrol; 2015 Apr; 19(2):197-207. PubMed ID: 24845230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-specific patterns of left ventricular and myocyte remodeling following myocardial infarction in mice deficient in the angiotensin II type 1a receptor.
    Bridgman P; Aronovitz MA; Kakkar R; Oliverio MI; Coffman TM; Rand WM; Konstam MA; Mendelsohn ME; Patten RD
    Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H586-92. PubMed ID: 15764682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal hyporesponsiveness to atrial natriuretic peptide in congestive heart failure results from reduced atrial natriuretic peptide receptor concentrations.
    Bryan PM; Xu X; Dickey DM; Chen Y; Potter LR
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1636-44. PubMed ID: 17264312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, Not NPR-A, is the predominant natriuretic peptide receptor in the failing heart.
    Dickey DM; Flora DR; Bryan PM; Xu X; Chen Y; Potter LR
    Endocrinology; 2007 Jul; 148(7):3518-22. PubMed ID: 17412809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II-induced ventricular hypertrophy and extracellular signal-regulated kinase activation are suppressed in mice overexpressing brain natriuretic peptide in circulation.
    Takahashi N; Saito Y; Kuwahara K; Harada M; Kishimoto I; Ogawa Y; Kawakami R; Nakagawa Y; Nakanishi M; Nakao K
    Hypertens Res; 2003 Oct; 26(10):847-53. PubMed ID: 14621189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
    Springer J; Azer J; Hua R; Robbins C; Adamczyk A; McBoyle S; Bissell MB; Rose RA
    J Mol Cell Cardiol; 2012 May; 52(5):1122-34. PubMed ID: 22326431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gestational hypertension in atrial natriuretic peptide knockout mice and the developmental origins of salt-sensitivity and cardiac hypertrophy.
    Armstrong DW; Tse MY; O'Tierney-Ginn PF; Wong PG; Ventura NM; Janzen-Pang JJ; Matangi MF; Johri AM; Croy BA; Adams MA; Pang SC
    Regul Pept; 2013 Sep; 186():108-15. PubMed ID: 23981445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.